alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED

UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 08-6886

RONALD A. PEGUESE, Petitioner - Appellant,

v. GENE JOHNSON, Director, Virginia Department of Corrections, Respondent - Appellee.

Appeal from the United States District Court for the Eastern District of Virginia, at Norfolk. Walter D. Kelley, District Judge. (2:07-cv-00285-WDK-JEB)

Submitted: October 21, 2008 Decided: October 27, 2008

Before MICHAEL, TRAXLER, and DUNCAN, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Ronald A. Peguese, Appellant Pro Se. Mark R. Davis, Assistant Attorney General, Richmond, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Ronald A. Peguese seeks to appeal the district court’s order accepting the recommendation of the magistrate judge and denying relief on his 28 U.S.C. § 2254 (2000) petition. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this standard by demonstrating that reasonable jurists would find that any assessment of the constitutional claims by the district court is debatable or wrong and that any dispositive procedural ruling by the district court is likewise debatable. Miller-El

v. Cockrell , 537 U.S. 322, 336-38 (2003); Slack v. McDaniel , 529 U.S. 473, 484 (2000); Rose v. Lee , 252 F.3d 676, 683-84 (4th Cir. 2001). We have independently reviewed the record and conclude that Peguese has not made the requisite showing. Accordingly, we deny Peguese’s motion for a certificate of appealability and dismiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Richard James BEASLEY, petitioner, v. OHIO.

No. 18-6044.

Supreme Court of the United States

Jan. 7, 2019.

Petition for writ of certiorari to the Supreme Court of Ohio denied.
I

106TH CONGRESS

1ST SESSION H. R. 1959

To designate the Federal building located at 743 East Durango Boulevard

in San Antonio, Texas, as the ‘‘Adrian A. Spears Judicial Training Center’’.

IN THE HOUSE OF REPRESENTATIVES

MAY 26, 1999

Mr. GONZALEZ introduced the following bill; which was referred to the

Committee on Transportation and Infrastructure

A BILL

To designate the Federal building located at 743 East Durango Boulevard in San Antonio, Texas, as the ‘‘Adrian

A. Spears Judicial Training Center’’.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DESIGNATION.

4 The Federal building located at 743 East Durango

5 Boulevard in San Antonio, Texas, shall be known and des6 ignated as the ‘‘Adrian A. Spears Judicial Training Cen7 ter’’.

8 SEC. 2. REFERENCES.

9 Any reference in a law, map, regulation, document,

10 paper, or other record of the United States to the Federal
2

•HR 1959 IH

1 building referred to in section 1 shall be deemed to

2 reference to the ‘‘Adrian A. Spears Judicial Training

3 Center’’.

Æ
Arika MATELYAN, petitioner, v. ATLANTIC RECORDS WMG, et al.

No. 18-5829.

Supreme Court of the United States

Oct. 29, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Exhibit 10.11
 AGREEMENT TO TERMINATE
THE LICENSE AND COOPERATION AGREEMENT
WITH RESPECT TO NEUROBIOLOGICAL TECHNOLOGIES, INC.
  Whereas
 Whereas
 Whereas
 Whereas
 Now, therefore,




---



##### 



Date:
    
    06 August 2009




---



##### 



By:
    
    /s/ Dr. Martin ZugelName:
    
    Dr. Martin ZugelTitle:
    
    CEOMerz Pharmaceuticals GmbHDate:
    
    06 August 2009By:
    
    /s/ Patrick M. JochumName:
    
    Patrick M. JochumTitle:
    
    Chief Litigation CounselNeurobiological Technologies, Inc.Date:
    
    Aug. 7, 2009By:
    
    /s/ Matthew M. LoarName:
    
    Matthew M. LoarTitle:
    
    Chief Financial Officer
    Date:
    
    August 7, 2009By:
    
    /s/ Erik HalvorsenName:
    
    Erik HalvorsenTitle:
    
    Director Technology & Business Development
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           3,969
<SECURITIES>                                         0
<RECEIVABLES>                                   27,643
<ALLOWANCES>                                     (800)
<INVENTORY>                                          0
<CURRENT-ASSETS>                                35,742
<PP&E>                                         379,907
<DEPRECIATION>                               (171,940)
<TOTAL-ASSETS>                                 280,551
<CURRENT-LIABILITIES>                           32,634
<BONDS>                                        270,741
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           119
<OTHER-SE>                                    (23,673)
<TOTAL-LIABILITY-AND-EQUITY>                   280,551
<SALES>                                         44,269
<TOTAL-REVENUES>                                44,269
<CGS>                                           19,005
<TOTAL-COSTS>                                   19,005
<OTHER-EXPENSES>                                25,130
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,874
<INCOME-PRETAX>                               (24,726)
<INCOME-TAX>                                       100
<INCOME-CONTINUING>                           (24,826)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (24,826)
<EPS-BASIC>                                     (2.08)
<EPS-DILUTED>                                   (2.08)


</TABLE>
```
 
 
CRUDE OIL, LIGHT SWEET - ICE FUTURES EUROPE                          Code-067411
FUTURES ONLY POSITIONS AS OF 10/30/12                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(CONTRACTS OF 1,000 BARRELS)                         OPEN INTEREST:      521,955
COMMITMENTS
  69,459   58,225  148,181  259,895  299,364  477,535  505,770   44,420   16,185

CHANGES FROM 10/23/12 (CHANGE IN OPEN INTEREST:     12,529)
   4,134    1,259    2,136  -16,606    6,230  -10,336    9,625   22,865    2,904

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    13.3     11.2     28.4     49.8     57.4     91.5     96.9      8.5      3.1

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      151)
      38       33       54       69       63      140      122
```

----

Updated November 2, 2012
EX-4.1.1





 Exhibit 4.1.1 

AMENDMENT NO. 1 TO THE PATENT LICENSE AGREEMENT NO. C-00061901 

BETWEEN 
 L’Institut Pasteur, a public
interest foundation, 25, rue du Docteur Roux, 75015 Paris, represented by Mr. Jean Castex, adjunct General Manager for administration and finance, and by Mr. Christian POLICARD, Director of Business Development and Industrial Partnerships.

 Hereafter referred to as “IP” or the “LICENSOR”, acting both on its own behalf and on behalf of: 

 

	 	•	 	 Université Pierre et Marie Curie, 



4, place de Jussieu, 
 75252 Paris
Cedex 05, 
 Hereafter referred to as “UPMC”, 
  

	 	•	 	 Le Centre National de la Recherche Scientifique, 



3, rue Michel-Ange, 
 75794 Paris
Cedex 16 
 Hereafter referred to as “CNRS”. 

Jointly also referred to as the “LICENSOR”, 
 Party
of the first part, 
 AND: 
 CELLECTIS, a
public limited company with a capital of 123,463.48 euros, headquartered at 28, rue du Docteur Roux, 75724 Paris cedex 15, represented by Mr. André Choulika, acting as Chief Executive Officer 

Hereafter referred to as “CELLECTIS” or the “LICENSEE”, 

Party of the second part. 
 The LICENSOR and LICENSEE are
hereafter referred to as the “Parties”. 
 RECITALS: 

The parties signed a patent and patent application license agreement on June 19, 2000 related to the gene of the I-Sce I enzyme, the expression of
the I-Sce I enzyme and its use. 
 Article 2.6 of the agreement stipulates that the IMPROVEMENTS achieved by the LICENSOR be granted under an
exclusive license to the LICENSEE in accordance with the terms and restrictions of the contract, for no additional charge. 
 The LICENSOR has now achieved
a technological improvement which it wishes in this amendment to grant to the Licensee. 












 It is thus agreed as follows: 

ARTICLE 1 
 The Parties agree to add to Article 1.2,
“AGREEMENT PATENTS”, U.S. patent application no. US 275,638 filed on March 15, 2001 and titled “Characterization of the I-SpomI Endonuclease from fission yeast”, including the PCT extension of this application, published
under no. WO 02/ 074965, the patent applications and patents resulting therefrom, any patent applications claiming priority over one of the aforementioned applications, any divisional applications, any continuing applications or any applications for
re-issue filed on the basis of the aforementioned patents and patent applications. 
 The LICENSOR agrees to provide
all KNOW-HOW pertaining thereto, notably the biological material containing the coding sequences for endonuclease I-SpomI and the sequences corresponding to the cleavage site for endonuclease I-SpomI. 

ARTICLE 2 
 The other provisions of the AGREEMENT
remain unchanged and continue to apply between the Parties. 
 This amendment shall enter into force on the date of filing of the priority patent
application on March 15, 2001. 
  

			
	Signed in Paris on	  	[Handwritten text: December 20, 2002]
	In 2 original copies.	  	

  

			
	CELLECTIS	  	INSTITUT PASTEUR
Carl Anthony WEBB, petitioner, v. Lorie DAVIS, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

No. 18-5627.

Supreme Court of the United States

Oct. 15, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Exhibit 31.1

CERTIFICATIONS

I, Christopher E. Herald certify that:

1.          I have reviewed this annual report on Form 10-K of Solitario Resources Corporation for the year ended December 31, 2006;

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

4.          The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have: 

               a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

               b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

               c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.          The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

               (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

               (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
EXHIBIT 

5

Case 5:23-cv-00032-RWS Document 110-5 Filed 05/17/24 Page 1 of 4 PageID #: 1962
App. 28

Case 5:23-cv-00032-RWS Document 110-5 Filed 05/17/24 Page 2 of 4 PageID #: 1963
App. 29

Case 5:23-cv-00032-RWS Document 110-5 Filed 05/17/24 Page 3 of 4 PageID #: 1964
App. 30

Case 5:23-cv-00032-RWS Document 110-5 Filed 05/17/24 Page 4 of 4 PageID #: 1965
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF TEXAS

MARSHALL DIVISION

AUTOSCRIBE CORPORATION

v. 

M&A Ventures, LLC

§

§ 

§ 

§ 

§ 

§

Case No. 2:23-cv-0349-JRG

JURY TRIAL DEMANDED

JOINT MOTION TO EXTEND THE P.R. 4-3 JOINT CONSTRUCTION STATEMENT 

DEADLINE TO AUGUST 2, 2024 

Comes Now, Plaintiff Autoscribe Corporation and Defendant M&A Ventures, LLC1

hereby file their Joint Motion to Extend the deadline to comply with P.R. 4-3 (Joint Claim 

Construction Statement), and in support thereof, would show as follows: 

1. Per Dkt. 34, the deadline to comply with P.R. 4-3 (Joint Claim Construction Statement)

is currently July 29, 2024. 

2. The parties are presently conferring to narrow the scope of claim construction issues in

dispute and anticipate being able to present a finalized version by August 2, 2024. The 

parties respectfully request a four-day extension to submit their Joint Claim 

Construction Statement. 

3. This Motion is not filed for the purpose of delay, and the parties jointly agreed to the 

relief requested herein.

Dated: July 26, 2024 

1

 The other parties in this case have been dismissed. 

Case 2:23-cv-00349-JRG Document 95 Filed 07/26/24 Page 1 of 3 PageID #: 2795
2 

Respectfully submitted,

/s/ Jason McManis 

Jason McManis

State Bar No.: 24088032 

Colin Phillips

State Bar No.: 24105937 

Chun Deng 

State Bar No.: 24133178 

Michael Killingsworth

State Bar No.: 24110089 

Angela Peterson

State Bar No.: 24137111 

Ahmad, Zavitsanos & Mensing, PLLC 

1221 McKinney Street, Suite 2500 

Houston, Texas 77010

(713) 655-1101 

jmcmanis@azalaw.com

cphillips@azalaw.com

cdeng@azalaw.com

apeterson@azalaw.com

mkillingsworth@azalaw.com 

Andrea L. Fair

State Bar No.: 24078488 

Ward, Smith, & Hill, PLLC

1507 Bill Owens Parkway 

Longview, Texas 75604

(903) 757-6400 

(903) 757-2323 (fax) 

andrea@wsfirm.com 

Attorneys for Autoscribe Corporation

/s/ Stephanie N. Sivinski

David H. Harper (Lead Counsel)

Texas Bar No. 09025540 

david.harper@haynesboone.com 

Stephanie N. Sivinski 

Texas Bar No. 24075080 

stephanie.sivinski@haynesboone.com 

Marron E. Frith 

TX Bar No. 24137884 

marron.frith@haynesboone.com 

HAYNES AND BOONE, LLP

2801 N. Harwood Street 

Suite 2300 

Dallas, Texas 75201 

(214) 651-5000 (telephone) 

(214) 200-0615 (fax) 

COUNSEL FOR DEFENDANT M&A

VENTURES, LLC

Case 2:23-cv-00349-JRG Document 95 Filed 07/26/24 Page 2 of 3 PageID #: 2796
3 

CERTIFICATE OF SERVICE

I hereby certify that on July 26, 2024, a true and correct copy of the above and foregoing 

document was filed electronically. As such, this document was served on all counsel of record 

pursuant to the Federal Rules of Civil Procedure. 

/s/ Jason McManis

Jason McManis

CERTIFICATE OF CONFERENCE

 I hereby certify that on July 25, 2024 the parties conferred regarding the Motion, and the 

parties jointly requested the relief thought herein. 

/s/ Jason McManis

Jason McManis

Case 2:23-cv-00349-JRG Document 95 Filed 07/26/24 Page 3 of 3 PageID #: 2797
<PAGE>
                                                                      EXHIBIT 24

                               POWERS OF ATTORNEY
                               ------------------

                               OLYMPIC STEEL, INC.
                               -------------------

         KNOW ALL MEN BY THESE PRESENTS, that OLYMPIC STEEL, INC., an Ohio
corporation, and each person whose name is signed below hereby constitute and
appoint Michael D. Siegal and Richard T. Marabito their attorneys-in-fact and
agents, with full power of substitution and resubstitution, for and on behalf of
Olympic Steel, Inc. and the undersigned Directors and officers of Olympic Steel,
Inc., and each of such Directors and officers, to sign Olympic Steel, Inc.'s
Annual Report on Form 10-K for the year ended December 31, 2003, any or all
amendments thereto, and to file the same, with exhibits thereto and other
documents in connection therewith, with the Securities and Exchange Commission,
granting such attorneys-in-fact and agents full power and authority to do and
perform each and every act and thing requisite and necessary in connection with
such matters and hereby ratifying and confirming all that such attorneys-in-fact
and agents or their substitute or substitutes may do or cause to be done by
virtue hereof.

         This Power of Attorney of Olympic Steel, Inc., and the Directors and
officers of Olympic Steel, Inc. may be executed in multiple counterparts, each
of which shall be deemed an original with respect to the person executing it.

         IN WITNESS WHEREOF, this Power of Attorney has been signed at
__________________, _____________ this _____ day of March, 2004.

                                    OLYMPIC STEEL, INC.

                                    By: /s/ Richard T. Marabito
                                       ---------------------------------
                                       Richard T. Marabito, Chief
                                       Financial Officer

DIRECTORS AND OFFICERS:

/s/ Martin H. Elrad                 /s/ Michael D. Siegal
-------------------------------     -----------------------------------
Martin H. Elrad, Director           Michael D. Siegal, Chairman of the
                                    Board and Chief Executive Officer

/s/ Thomas M. Forman                /s/ David A. Wolfort
-------------------------------     -----------------------------------
Thomas M. Forman, Director          David A. Wolfort, President, Chief
                                    Operating Officer and Director

/s/ Suren A. Hovsepian              /s/ Richard T. Marabito
-------------------------------     -----------------------------------
Suren A. Hovsepian, Director        Richard T. Marabito, Chief Financial
                                    Officer (Principal Accounting Officer)

/s/ James B. Meathe                 /s/ Howard L. Goldstein
-------------------------------     -----------------------------------
James B. Meathe, Director           Howard L. Goldstein, Director
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2143 Introduced in House (IH)]

106th CONGRESS
  1st Session
                                H. R. 2143

        To suspend for 3 years the duty on 2,6-dichlorotoluene.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             June 10, 1999

 Mr. English introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
        To suspend for 3 years the duty on 2,6-dichlorotoluene.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TEMPORARY SUSPENSION OF DUTY ON 2,6-DICHLOROTOLUENE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.32.82       2,6-                Free         No change        No change        On or before 12/
                         dichlorotoluene                                                    31/2002          ''.
                         (provided for in
                         subheading
                         2903.69.70)......

    (b) Effective Date.--The amendment made by this section shall apply 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of enactment of 
this Act.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           4,100
<SECURITIES>                                         0
<RECEIVABLES>                                  365,400
<ALLOWANCES>                                     5,400
<INVENTORY>                                    342,300
<CURRENT-ASSETS>                               785,700
<PP&E>                                         505,100
<DEPRECIATION>                                 209,000
<TOTAL-ASSETS>                               1,274,100
<CURRENT-LIABILITIES>                          578,700
<BONDS>                                         75,300
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           200
<OTHER-SE>                                     387,500
<TOTAL-LIABILITY-AND-EQUITY>                 1,274,100
<SALES>                                      1,176,700
<TOTAL-REVENUES>                             1,176,700
<CGS>                                          897,400
<TOTAL-COSTS>                                  897,400
<OTHER-EXPENSES>                               233,700
<LOSS-PROVISION>                                 1,000
<INTEREST-EXPENSE>                               4,400
<INCOME-PRETAX>                                 40,200
<INCOME-TAX>                                    14,900
<INCOME-CONTINUING>                             25,300
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    25,300
<EPS-BASIC>                                       1.03
<EPS-DILUTED>                                     1.02


</TABLE>
James Lee WILLIAMS, petitioner, v. UNITED STATES.

No. 18-571.

Supreme Court of the United States

Jan. 7, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
Juliette FAIRLEY, petitioner, v. PM MANAGEMENT-SAN ANTONIO AL.

No. 18-6446.

Supreme Court of the United States

Jan. 7, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.